Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator
ID: 355880Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCCDPHP (HHS-CDC-NCCDPHP)

Award Range

$750K - $3M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355880
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Public Health Strategies to Address Alzheimer's Disease and Related Dementias," aimed at enhancing public health initiatives through cooperative agreements. This initiative seeks to support organizations in developing and implementing strategies that align with the National Healthy Brain Initiative Road Map Series, focusing on areas such as dementia risk reduction, early detection, management, and caregiver support. The funding opportunity is critical as it addresses the rising prevalence of Alzheimer's disease, which significantly impacts public health, particularly among the aging U.S. population. Interested applicants can apply for one or more of the three components, with funding amounts ranging from $750,000 to $3 million, and must submit their applications by March 7, 2025, to be considered for awards expected to be announced by July 15, 2025. For further inquiries, applicants can contact Alisha Etheredge at BOLD@cdc.gov or call 770-488-7884.

    Point(s) of Contact
    Alisha Etheredge
    (770) 488-7884
    BOLD@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Demonstrations Reducing Dementia Disparities
    Active
    Office of the Assistant Secretary for Health
    The Office of the Assistant Secretary for Health is forecasting a federal grant opportunity titled "Demonstrations Reducing Dementia Disparities" aimed at funding innovative projects that address health disparities related to brain health in aging populations. The initiative seeks to support evidence-based and community-focused approaches that tackle social determinants of health and improve outcomes for groups disproportionately affected by dementia and related chronic illnesses. With an estimated total program funding of $5 million, the agency plans to award approximately nine grants, each ranging from $500,000 to $600,000, with applications due by February 13, 2025. Interested applicants can reach out to Alana Sutherland at OMHGrants@hhs.gov or by phone at 301-945-3668 for further information.
    Alzheimer's Disease Programs Initiative (ADPI) - Developing Dementia-Capable Community Health Worker Programs in the National Aging Network
    Active
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled "Alzheimer's Disease Programs Initiative (ADPI) - Developing Dementia-Capable Community Health Worker Programs in the National Aging Network." This initiative aims to establish twelve three-year cooperative agreements with Home and Community-Based Service organizations to enhance the dementia capabilities of Community Health Worker (CHW) programs, thereby equipping CHWs to better support individuals living with dementia and their caregivers through specialized training and culturally competent resources. The program is crucial for increasing access to meaningful support for family caregivers, aligning with recommendations from the RAISE Act Family Caregiving Advisory Council. Interested applicants, specifically private institutions of higher education, should note that the award ceiling is set at $250,000, with a total estimated program funding of $6 million, and the application period is expected to open in March 2025, with awards anticipated by August 2025. For further inquiries, contact Stephanie Bostic at stephanie.bostic@acl.hhs.gov or call 202-795-7345.
    Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation," aimed at enhancing educational resources for families affected by CJD and related prion diseases. The cooperative agreement seeks to provide timely information to families, public health service providers, and health professionals to improve monitoring and understanding of prion diseases, particularly in light of the ongoing chronic wasting disease (CWD) outbreak among deer and elk. Eligible applicants include states, political subdivisions, and nonprofit entities, with funding ranging from $75,000 to a maximum of $100,000, and an estimated total program funding of $500,000. Interested parties should note that applications must be submitted electronically by March 18, 2025, with awards expected to be announced by September 1, 2025; for further inquiries, contact Tracey Ponder at TPonder@cdc.gov or by phone at 404-639-0953.
    Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to address significant gaps in lupus awareness and care by supporting national organizations in reducing the time to diagnosis, improving care coordination, and enhancing self-management among lupus patients. The program is particularly focused on increasing healthcare provider education and promoting effective self-management tools for individuals affected by lupus, a systemic autoimmune disease that disproportionately impacts women, especially those from minority communities. The estimated total program funding is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are due by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.
    Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for early and late-stage clinical trials focused on Alzheimer's Disease (AD) and related dementias, as well as age-related cognitive decline. This initiative aims to develop and implement both pharmacological and non-pharmacological interventions to address cognitive and neuropsychiatric changes associated with these conditions, while also encouraging innovative trial designs and methodologies. Given the significant public health crisis posed by AD, which currently affects over six million Americans, this funding opportunity is part of a broader strategy to enhance research and develop effective therapies across the disease spectrum. Applications are due by January 7, 2025, and interested parties can find more information and submit proposals through the NIH ASSIST online system or contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing Public Health Actions to Prevent and Control Chronic Disease in the U.S. Territories and Freely Associated States
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Advancing Public Health Actions to Prevent and Control Chronic Disease in the U.S. Territories and Freely Associated States." This initiative aims to enhance public health efforts by implementing integrated, evidence-based strategies to prevent and manage chronic diseases, particularly in jurisdictions facing unique challenges such as high disease burdens and limited healthcare infrastructure. The program emphasizes addressing modifiable risk factors, including tobacco use and diabetes management, and consists of a mandatory Core Component and an optional Oral Health Component. Interested applicants, including state and local governments, nonprofit organizations, and tribal governments, can apply for a share of the estimated $17.45 million in funding, with applications due by January 15, 2025. For further inquiries, applicants may contact Monique Young at islandprogdp25-0024@cdc.gov.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. The initiative seeks to enhance AGS surveillance, patient care, and public understanding through strategies that include public health tracking, targeted education for at-risk populations, and dissemination of knowledge among stakeholders. With an estimated total program funding of $2,250,000, the CDC anticipates awarding three grants, with individual awards ranging from $25,000 to $1,000,000. Interested applicants can reach out to Jeff Borchert at JBorchert@cdc.gov or by phone at 970-221-6494, with applications due by January 22, 2025, and awards expected to be announced by July 1, 2025.
    Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment or renewal of Alzheimer's Disease Research Centers (ADRCs) through Grant Opportunity RFA-AG-24-001. This initiative aims to foster multidisciplinary collaboration and resource sharing among institutions dedicated to researching Alzheimer's Disease (AD) and related dementias (ADRD), with a focus on enhancing diverse perspectives in research. The program will provide a total of $32 million for seven awards in FY 2024, increasing to $65 million for 14 awards in both FY 2025 and FY 2026, with a maximum project budget of $2.925 million per year and a project period of up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with the application deadline set for September 26, 2025.
    RFA-DD-18-000
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-DD-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program expected to award approximately 10 grants. This funding is crucial for enhancing public health efforts, although specific funding amounts have not been disclosed. Interested parties should submit their applications by October 13, 2025, and can direct inquiries to Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
    Alzheimer's Disease Programs Initiative (ADPI) - States and Community Grants (Winter 2025)
    Active
    Administration for Community Living
    The Administration for Community Living is forecasting the availability of the Alzheimer's Disease Programs Initiative (ADPI) - States and Community Grants for Winter 2025, aimed at enhancing dementia-capable home and community-based service systems. This opportunity includes two application options: Grants to States, which focus on creating and sustaining state-level dementia-capable systems, and Grants to Communities, which target community-based organizations addressing specific service gaps for individuals living with Alzheimer's disease and related dementias. With an estimated total program funding of $30 million, the initiative anticipates awarding approximately 30 cooperative agreements, with individual awards ranging from $850,000 to $1 million. Interested applicants can find more information and contact Erin Long at Erin.Long@acl.hhs.gov or by phone at 202-795-7389, with applications expected to open in March 2025 and close in May 2025.